REG - Nippon Active Value - Hogy Medical Co Ltd Tender Offer

Nippon Active Value FundAnnouncement

17/12/2025 13:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251217:nRSQ9837La&default-theme=true

RNS Number : 9837L  Nippon Active Value Fund PLC  17 December 2025

LEI: 213800JOFEGZJYS21P75

 

Nippon Active Value Fund plc

Hogy Medical Tender Offer

Successful portfolio company actions

Nippon Active Value Fund plc ("NAVF"), targeting attractive returns by active
engagement with undervalued Japanese equities, is delighted to today announce
that TCG2509 K.K. (the "Offering Vehicle"), an entity which is indirectly
owned by CJP V HC Holdings VII, L.P., a fund sponsored and managed by Carlyle,
has announced the launch of a tender offer for the shares in Hogy Medical Co.,
Ltd. ("Hogy Medical") (the "Tender Offer") as a part of the transaction where
the Offering Vehicle is proposing to acquire all of the shares in Hogy Medical
and takes it private (the "Transaction").

NAVF, acting on the recommendation of its investment adviser, Rising Sun
Management Limited, and certain co-investors in Hogy Medical (Dalton
Investments, Inc. and NAVF Select LLC, the "Co-Investors") have agreed to
tender all of their existing holdings in Hogy Medical in the Tender Offer,
representing 27.58% of Hogy Medical's issued share capital. NAVF's own holding
in Hogy Medical amounts to 8.58% of Hogy Medical's issued share capital.

Hogy Medical is expected to be delisted from the Tokyo Stock Exchange
following the completion of the Transaction.

NAVF is pleased that subject to the completion of the squeeze out of minority
shareholders of Hogy Medical subsequent to the Tender Offer, NAVF and the
Co-Investors have agreed with the Offering Vehicle that NAVF and the
Co-Investors will reinvest an amount of their tender offer proceeds for LP
interests in a limited partnership to be formed by Carlyle, which amounts to,
indirectly, a total of up to 20% of the economic interest in CJP V HC Holdings
VII, L.P. (the "Reinvestment"). The precise terms of the Reinvestment are
subject to good faith discussions between NAVF, the Co-Investors and the
Offering Vehicle.

NAVF's holding in Hogy Medical was valued at £55.2m, representing 13.0% of
the net asset value of NAVF, as at 30 November 2025. The Tender Offer Price
represents a value of approximately £62.4m for NAVF's entire holding, based
on the Bloomberg foreign exchange rate as at 17 December 2025.

Furthermore, pursuant to the reinvestment agreement, NAVF and the Co-Investors
will have a right to nominate a director of the holding company of the
Offering Vehicle.

As part of its investment mandate, NAVF is permitted to hold up to 10% of NAV
in unlisted investments. The Reinvestment will be well within this limit.

NAVF believes that Hogy Medical has a bright future under its new ownership, a
future in which NAVF is pleased to continue its participation.

ENQUIRIES

 Shore Capital                 +44 20 7408 4050

 Gillian Martin / Daphne Zhang / Matthew Walton (Corporate Advisory)

Fiona Conroy (Corporate Broking)
 Peregrine Communications, PR  +44 20 3178 6868

 Bill McIntosh                 bill.mcintosh@peregrinecommunications.com

Alex Gorokhov                (mailto:bill.mcintosh@peregrinecommunications.com)
                               alex.gorokhov@peregrinecommunications.com
                               (mailto:alex.gorokhov@peregrinecommunications.com)

 

NOTES TO EDITORS

About NAVF

Nippon Active Value Fund ("NAVF") is an Investment Trust listed on the Main
Market of the London Stock Exchange. The investment advisor of NAVF is Rising
Sun Management Limited. NAVF is targeting attractive levels of capital growth
for shareholders from the active management of a focused portfolio of
(predominantly) quoted Japanese equity investments. Rising Sun Management
Limited, with its local presence in Tokyo, targets companies which are
attractive, undervalued and have a substantial proportion of their market
capitalisation held in cash and/or listed securities and/or realisable assets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TENUBRORVBUUAAA



            Copyright 2019 Regulatory News Service, all rights reserved